• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米医学:控制纳米颗粒清除率以实现转化成功。

Nanomedicine: controlling nanoparticle clearance for translational success.

机构信息

Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.

Department of Surgical Biotechnology, University College London, London, UK.

出版信息

Trends Pharmacol Sci. 2022 Sep;43(9):709-711. doi: 10.1016/j.tips.2022.05.001. Epub 2022 May 31.

DOI:10.1016/j.tips.2022.05.001
PMID:35659416
Abstract

Achieving complete nanoparticle (NP) clearance is a key consideration in the design of safe and translatable nanomedicines. Renal-clearable nano formulations must encompass the beneficial nanoscale functionalities whilst exhibiting clearance profiles like those of small-molecule therapeutics. Recent developments in the field have enabled the growth of novel renal-clearable NPs with transformable sizes that take advantage of alternative clearance mechanisms to achieve controlled and efficient renal excretion to improve potential clinical translation.

摘要

实现完全的纳米颗粒 (NP) 清除是安全且可转化的纳米药物设计的关键考虑因素。肾脏可清除的纳米制剂必须包含有益的纳米级功能,同时表现出与小分子治疗剂相似的清除特征。该领域的最新进展使得具有可转换尺寸的新型肾脏可清除 NP 的生长成为可能,这些 NP 利用替代清除机制来实现可控和有效的肾脏排泄,以提高潜在的临床转化。

相似文献

1
Nanomedicine: controlling nanoparticle clearance for translational success.纳米医学:控制纳米颗粒清除率以实现转化成功。
Trends Pharmacol Sci. 2022 Sep;43(9):709-711. doi: 10.1016/j.tips.2022.05.001. Epub 2022 May 31.
2
Translational formulation of nanoparticle therapeutics from laboratory discovery to clinical scale.从实验室发现到临床规模的纳米药物治疗的转化配方。
J Transl Med. 2019 Jun 14;17(1):200. doi: 10.1186/s12967-019-1945-9.
3
Nanomedicines for Renal Management: From Imaging to Treatment.纳米医学在肾脏管理中的应用:从成像到治疗。
Acc Chem Res. 2020 Sep 15;53(9):1869-1880. doi: 10.1021/acs.accounts.0c00323. Epub 2020 Aug 12.
4
Renal clearable nanocarriers: Overcoming the physiological barriers for precise drug delivery and clearance.肾可清除纳米载体:克服生理屏障以实现精准药物递送与清除
J Control Release. 2020 Jun 10;322:64-80. doi: 10.1016/j.jconrel.2020.03.020. Epub 2020 Mar 16.
5
Clinical translation of nanomedicines: Challenges, opportunities, and keys.纳米药物的临床转化:挑战、机遇与要点。
Adv Drug Deliv Rev. 2022 Feb;181:114083. doi: 10.1016/j.addr.2021.114083. Epub 2021 Dec 17.
6
Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine.了解纳米颗粒内吞作用以改善纳米医学中的靶向策略。
Chem Soc Rev. 2021 May 7;50(9):5397-5434. doi: 10.1039/d0cs01127d. Epub 2021 Mar 5.
7
Imaging Nano-Bio Interactions in the Kidney: Toward a Better Understanding of Nanoparticle Clearance.在肾脏中成像纳米生物相互作用:深入了解纳米颗粒清除。
Angew Chem Int Ed Engl. 2018 Mar 12;57(12):3008-3010. doi: 10.1002/anie.201711705. Epub 2018 Feb 16.
8
Albumin Nanoparticles Increase the Efficacy of Doxorubicin Hydrochloride Liposome Injection Based on Threshold Theory.白蛋白纳米粒基于阈理论增加盐酸多柔比星脂质体注射液的疗效。
Mol Pharm. 2024 Jun 3;21(6):2970-2980. doi: 10.1021/acs.molpharmaceut.4c00097. Epub 2024 May 14.
9
Challenges in nanomedicine clinical translation.纳米医学临床转化的挑战。
Drug Deliv Transl Res. 2020 Jun;10(3):721-725. doi: 10.1007/s13346-020-00740-5.
10
Advancing Nanomedicine Through Electron Microscopy: Insights Into Nanoparticle Cellular Interactions and Biomedical Applications.通过电子显微镜推进纳米医学:对纳米颗粒与细胞相互作用及生物医学应用的见解。
Int J Nanomedicine. 2025 Mar 8;20:2847-2878. doi: 10.2147/IJN.S500978. eCollection 2025.

引用本文的文献

1
Mass Spectrometry Imaging Reveals That Gold Nanomaterial Surface Chemistry Affects Transport and Excretion in Mice over Time.质谱成像显示,金纳米材料的表面化学性质会随时间影响其在小鼠体内的转运和排泄。
Chem Biomed Imaging. 2025 Jan 3;3(7):443-454. doi: 10.1021/cbmi.4c00082. eCollection 2025 Jul 28.
2
Characterization of free light chain impurity in a bispecific antibody.双特异性抗体中游离轻链杂质的表征
MAbs. 2025 Dec;17(1):2527689. doi: 10.1080/19420862.2025.2527689. Epub 2025 Jul 3.
3
Developments in nanotechnology approaches for the treatment of solid tumors.
用于治疗实体瘤的纳米技术方法的进展
Exp Hematol Oncol. 2025 May 19;14(1):76. doi: 10.1186/s40164-025-00656-1.
4
Poly(2-(diethylamino)ethyl methacrylate)-Functionalized Carbon Nanodots as Theranostic Platforms for siRNA Delivery and Survivin Silencing in Triple-Negative Breast Cancer.聚(甲基丙烯酸2-(二乙氨基)乙酯)功能化碳纳米点作为三阴性乳腺癌中用于siRNA递送和Survivin基因沉默的诊疗平台
Biomacromolecules. 2025 Jun 9;26(6):3666-3679. doi: 10.1021/acs.biomac.5c00267. Epub 2025 May 10.
5
Advances in Ultrasmall Inorganic Nanoparticles for Nanomedicine: From Diagnosis to Therapeutics.用于纳米医学的超小无机纳米颗粒的进展:从诊断到治疗
ACS Appl Mater Interfaces. 2025 May 21;17(20):28982-29001. doi: 10.1021/acsami.5c02810. Epub 2025 May 9.
6
Kinetically Arrested SERS-Active Aggregates for Biosensing.用于生物传感的动力学捕获表面增强拉曼散射活性聚集体
Chemistry. 2025 Jul 8;31(38):e202500915. doi: 10.1002/chem.202500915. Epub 2025 Jun 17.
7
Targeted Boron Neutron Capture Therapy Using Polymalic Acid Derived Nano-Boron to Treat Glioblastoma.使用聚苹果酸衍生的纳米硼进行靶向硼中子俘获疗法治疗胶质母细胞瘤。
J Oncol Res Ther. 2024;9. doi: 10.29011/2574-710x.10226. Epub 2024 Jun 17.
8
Cutting-edge nanotechnology: unveiling the role of zinc oxide nanoparticles in combating deadly gastrointestinal tumors.前沿纳米技术:揭示氧化锌纳米颗粒在对抗致命胃肠道肿瘤中的作用。
Front Bioeng Biotechnol. 2025 Mar 20;13:1547757. doi: 10.3389/fbioe.2025.1547757. eCollection 2025.
9
Magnetic-Plasmonic Core-Shell Nanoparticles: Properties, Synthesis and Applications for Cancer Detection and Treatment.磁性等离子体核壳纳米粒子:癌症检测与治疗的性质、合成及应用
Nanomaterials (Basel). 2025 Feb 10;15(4):264. doi: 10.3390/nano15040264.
10
Gold nanocomposites in colorectal cancer therapy: characterization, selective cytotoxicity, and migration inhibition.用于结直肠癌治疗的金纳米复合材料:表征、选择性细胞毒性及迁移抑制
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan 29. doi: 10.1007/s00210-025-03839-z.